Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SOON IL LEE
Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status
Oncology Letters
Cancer Research
Oncology
Related publications
Oxaliplatin With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFOX 4) as First-Line Therapy for Patients With Metastatic Colorectal Cancer
Cancer Research and Treatment
Cancer Research
Oncology
First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
S-1 With Leucovorin and Oxaliplatin for Advanced Gastric Cancer
The Lancet Oncology
Oncology
All-Trans-Retinoic Acid (ATRA) Plus Oxaliplatin Plus 5-Fluorouracil/Leucovorin (FOLFOX) Versus FOLFOX Alone as Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma and Extrahepatic Metastasis: Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
Sorafenib in Combination With Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-Line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial
Clinical Cancer Research
Cancer Research
Oncology
A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Comparative Analysis of the Efficacy and Safety of Chemotherapy With Oxaliplatin Plus Fluorouracil/Leucovorin Between Elderly Patients Over 65 Years and Younger Patients With Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Effects of Modified FOLFOX-6 Chemotherapy on Cellular Immune Function in Patients With Gastric Cancer
Oncology Letters
Cancer Research
Oncology
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology